alymsys
mabxience research sl - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - antineoplastische middelen - alymsys in combination with fluoropyrimidine based chemotherapy is indicated for treatment of adult patients with metastatic carcinoma of the colon or rectum. alymsys in combination with paclitaxel is indicated for first line treatment of adult patients with metastatic breast cancer. alymsys in combination with capecitabine is indicated for first line treatment of adult patients with metastatic breast cancer in whom treatment with other chemotherapy options including taxanes or anthracyclines is not considered appropriate. patients who have received taxane and anthracycline containing regimens in the adjuvant setting within the last 12 months should be excluded from treatment with alymsys in combination with capecitabine. alymsys, in addition to platinum based chemotherapy, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non small cell lung cancer other than predominantly squamous cell histology. alymsys, in combination with erlotinib, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non squamous non small cell lung cancer with epidermal growth factor receptor (egfr) activating mutations. alymsys in combination with interferon alfa 2a is indicated for first line treatment of adult patients with advanced and/or metastatic renal cell cancer. alymsys, in combination with carboplatin and paclitaxel is indicated for the front line treatment of adult patients with advanced (international federation of gynecology and obstetrics (figo) stages iii b, iii c and iv) epithelial ovarian, fallopian tube, or primary peritoneal cancer. alymsys, in combination with carboplatin and gemcitabine or in combination with carboplatin and paclitaxel, is indicated for treatment of adult patients with first recurrence of platinum sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents. alymsys, in combination with topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents. alymsys, in combination with paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan in patients who cannot receive platinum therapy, is indicated for the treatment of adult patients with persistent, recurrent, or metastatic carcinoma of the cervix.
magnate® 100 sl
adama - met water mengbaar concentraat (sl) - imazalil - fungicide
potazil 100 sl
adama - met water mengbaar concentraat (sl) - imazalil - fungicide
magnence 243 mg or. opl. (pdr.) sachet
kora corporation t/a kora healthcare ltd. - magnesiumaspartaatdihydraat 3246 mg - eq. magnesium 243 mg - poeder voor drank - 243 mg - magnesiumaspartaatdihydraat 3246 mg - magnesium aspartate
magnence 243 mg poeder voor drank
magnesiumaspartaat 2-water 3246 mg/stuk samenstelling overeenkomend met ; magnesium (mg2+) 243 mg/stuk - poeder voor drank - citroenzuur 1-water (e 330) ; perzik-abrikozensmaakstof ; saccharoide natrium x-water (e 954) ; saccharose ; siliciumdioxide (e 551)
tylogran, 1000 mg/g, granulaat voor gebruik in drinkwater/melk voor runderen (kalveren), varkens, kippen en kalkoenen
dopharma research b.v. - tylosinetartraat - granulaat voor gebruik in drinkwater - tylosinetartraat 1 g/g, - tylosin - kalkoenen; kalveren; kippen; varkens
tildosin, 250 mg/ml oplossing voor gebruik in drinkwater of kunstmelk voor runderen, varkens, kippen en kalkoenen
dopharma research b.v. - tilmicosine - oplossing voor gebruik in drinkwater - tilmicosine 250 mg/ml, - tilmicosin - kalkoenen; kippen; runderen; varkens
amoxy active ctd 697 mg/g, poeder voor gebruik in drinkwater voor kippen, kalkoenen en eenden
dopharma research b.v. - amoxicilline 0-water - poeder voor gebruik in drinkwater - amoxicilline 0-water 697 mg/g, - amoxicillin - eenden; kalkoenen; kippen
proposure 10 mg/ml emulsie voor injectie voor honden en katten
axience - propofol - emulsie voor injectie - propofol 10 mg/ml, - propofol - honden; katten
biocefa 50 mg tabletten voor honden en katten
axience - cefalexine 1-water - tablet - cefalexine 1-water 50 mg/stuk, - cefalexin - honden; katten